Skip to main content
Caplight Logo









Vanqua Bio

Vanqua Bio

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://www.vanquabio.com/

Last Round

Series B

Extension

Jul 1, 2024

Total Funding Raised

$130M

Company Overview

Vanqua Bio is a biopharmaceutical company that discovers and develops innovative medicines for neurodegenerative and inflammatory diseases through small-molecule activators of glucocerebrosidase and innate immune system targeting.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticaldrug discoverysmall-molecule therapyneurodegenerative diseasebiotechclinical trialsGCase activatorC5aR1 antagonistParkinson's diseaseinflammatory diseasedrug licensingbiotech startuptherapeutic developmentR&D partnershipclinical-stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vanqua Bio Comparables

Compare Vanqua Bio with similar companies based on industry and business-model similarity.

Vanqua Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gain Therapeutics Inc
88%
Neuron23
86%
Casma Therapeutics
78%

Vanqua Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJul 1, 2024
Series BSep 14, 2021
Series AOct 1, 2019

Vanqua Bio Investors

Notable investors and investment history

Vanqua Bio investors
InvestorRounds
Surveyor CapitalSeries B
SymBiosis Capital ManagementSeries B Extension
Omega FundsSeries B Extension, Series B
Avoro VenturesSeries B
Pontifax CreditSeries B
Osage University PartnersSeries B
OrbiMedSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 17, 2026

    Will present at the AD/PDTM 2026 conference in Copenhagen.

Vanqua Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vanqua Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vanqua Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range36
Year Founded2019
Last FundingJul 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?